CCL2 and hepatocellular carcinoma: Interestingly, CCL2/CCR2 targeting by CCR2 knockdown, CCR2 antagonists, neutralizing Abs, or RNA aptamers has been shown to inhibit malignant growth and metastasis, reduce postsurgical recurrence and enhance survival in different HCC models [143, 156, 162, 163].